Neuropace, Inc. NPCE Common stock, capital shares reserved for future issuance
Common stock, capital shares reserved for future issuance at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s common stock, capital shares reserved for future issuance.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s common stock, capital shares reserved for future issuance?
- Neuropace, Inc. (NPCE) reported common stock, capital shares reserved for future issuance of $8.47M in Q1 2026.
- How has Neuropace, Inc.'s common stock, capital shares reserved for future issuance changed year-over-year?
- Neuropace, Inc.'s common stock, capital shares reserved for future issuance increased by 6.5% year-over-year, from $7.95M to $8.47M.
- What is the long-term trend for Neuropace, Inc.'s common stock, capital shares reserved for future issuance?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s common stock, capital shares reserved for future issuance has grown at a -19.1% compound annual growth rate (CAGR), from $20.62M to $7.13M.